Markets

Calidi Biotherapeutics Receives NYSE American Non-Compliance Notice

Sep 25, 2026 · 05:03 PM ET· updated 50m ago

Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines, today announced that on September 21, 2026, the

Why It Matters

Calidi got a warning from the stock exchange about not following rules. When a company gets warnings like this, watch to see if they fix the problem quickly.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

CLDI1.18

-0.02 (-1.75%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.